Wen-Hua Lee

Alpha-tocopherol induces calnexin in renal tubular cells: another protective mechanism against free radical-induced cellular damage.

S. Toyokuni, Li Jiang, S. Akatsuka, 2006, Archives of biochemistry and biophysics.

A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy.

A. Kamb, Rabi Murad, D. Warshaviak, 2022, Toxicology and applied pharmacology.

Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis.

K. Sakumi, Y. Nakabeppu, S. Toyokuni, 2006, The American journal of pathology.

Asbestos surface provides a niche for oxidative modification

S. Toyokuni, H. Nagai, K. Okawa, 2011, Cancer science.

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

A. Kamb, M. Sandberg, C. Yao, 2021, Journal of immunotherapy.

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

A. Kamb, M. Sandberg, Xueyin Wang, 2022, Science Translational Medicine.

Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis

H. Masutani, J. Yodoi, S. Toyokuni, 2005, Laboratory Investigation.

Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment

S. Toyokuni, Li Jiang, S. Akatsuka, 2006, Cancer science.

Susceptibility of actin to modification by 4-hydroxy-2-nonenal.

S. Toyokuni, S. Akatsuka, K. Uchida, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer

D. Maloney, M. Borad, T. Welling, 2022, Regular and Young Investigator Award Abstracts.